Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-11,083
Closed -$1.96M 54
2017
Q4
$1.96M Sell
11,083
-1,115
-9% -$197K 1.3% 28
2017
Q3
$2.28M Sell
12,198
-1,410
-10% -$250K 1.69% 19
2017
Q2
$2.37M Sell
13,608
-260
-2% -$42.3K 1.89% 16
2017
Q1
$2.26M Sell
13,868
-980
-7% -$163K 1.77% 20
2016
Q4
$2.31M Buy
+14,848
New +$2.23M 2.02% 17

Other funds holding AMGN

CMH Wealth Management's AMGN Position: Q1 2018 in Review

CMH Wealth Management sold out of Amgen (AMGN) in Q1 2018, closing a stake of 11,083 shares — an estimated $1.96M sold.

CMH Wealth Management first reported a position in AMGN in Q4 2016 and held it in 5 quarters. The position peaked at $2.37M in Q2 2017. 1,749 funds tracked by Wall St. Rank hold AMGN as of Q1 2018.

  • CMH Wealth Management reported no remaining Amgen position as of Q1 2018 after selling out during the quarter.
  • CMH Wealth Management sold 11,083 Amgen shares in Q1 2018, an estimated $1.96M.
  • CMH Wealth Management first reported a position in Amgen in Q4 2016 and held it in 5 quarters.
  • CMH Wealth Management's Amgen position peaked at $2.37M in Q2 2017.
  • 1,749 funds tracked by Wall St. Rank held Amgen as of Q1 2018.

Based on CMH Wealth Management's 13F filing for Q1 2018, filed 11 Apr 2018.